TY - STAND
KW - Essential medicines
KW - Neglected tropical diseases (NTDs)
KW - Low and middle income countries
KW - Accessibility
KW - WHO
KW - Adults
KW - paediatric
AU - Fattah F
AU - Lester R
AU - Kalua K
AU - Sharp B
AU - Wasan K
AB - <jats:p>In July 2023, the World Health Organization (WHO) released the 23rd Model List of Essential Medicines (EML) for adults and the 9th Model List of EML for children. These lists serve as global references for essential medicines that should be universally available, accessible and affordable. This editorial explores recent updates to the WHO EML lists, with a particular focus on medicines addressing neglected tropical diseases (NTDs). We discuss the persistent barriers to equitable access, including economic, regulatory, and logistical challenges; highlight global initiatives aimed at improving accessibility; and propose strategies to bridge the gap in essential medicine access. We emphasize the need for international collaboration, increased funding for research institutions, pharmaceutical companies, and global health initiatives to support the development of novel treatments for NTDs, and innovative distribution approaches to ensure these medications reach underserved populations.</jats:p>
DA - 25/11/2025
DO - 10.20944/preprints202511.1861.v1
LA - ENG
M3 - Report
N2 - <jats:p>In July 2023, the World Health Organization (WHO) released the 23rd Model List of Essential Medicines (EML) for adults and the 9th Model List of EML for children. These lists serve as global references for essential medicines that should be universally available, accessible and affordable. This editorial explores recent updates to the WHO EML lists, with a particular focus on medicines addressing neglected tropical diseases (NTDs). We discuss the persistent barriers to equitable access, including economic, regulatory, and logistical challenges; highlight global initiatives aimed at improving accessibility; and propose strategies to bridge the gap in essential medicine access. We emphasize the need for international collaboration, increased funding for research institutions, pharmaceutical companies, and global health initiatives to support the development of novel treatments for NTDs, and innovative distribution approaches to ensure these medications reach underserved populations.</jats:p>
PB - MDPI AG
PY - 2025
SP - 1
EP - 10
TI - Equitable Access of Essential Medicines to Treat Neglected Tropical Diseases-Latest Developments from the World Health Organization (WHO)
UR - https://www.preprints.org/frontend/manuscript/813e0bba8208ffef6bb698152ff7f258/download_pub
ER -